drugset

drugset / Trial / NCT00676195

An Open-Label Study of N-Acetyl Cysteine in Children With Autism

NCT00676195 ↗

Phase 2 Completed 24 enrolled Stanford University

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to test the tolerability and efficacy of N-Acetyl Cysteine (NAC) in children with Autism.

Timeline

Start: 2008-06
Primary completion: 2010-06
Completion: 2010-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	N-acetylcysteine	Small molecule	900 mg	Oral

Indications